First phase III trial of dasiglucagon for the treatment of congenital hyperinsulinism
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2018
At a glance
- Drugs Dasiglucagon
- Indications Hyperinsulinaemia
- Focus Therapeutic Use
- 11 Apr 2018 According to a Zealand Pharma media release, company has entered a collaboration agreement with Roche Diabetes Care to use its Accu-Chek Combo pump system in the Phase 3 trials. This trial is expected to initiate in second half of 2018.
- 20 Mar 2018 According to a Zealand Pharma media release, in January 2018, the FDA issued a safe-to-proceed letter, and the Phase 3 program is expected to start in mid-2018.
- 23 Jan 2018 New trial record